IBIO logo

IBio (IBIO) Cash From Operations

Annual CFO

-$18.55 M
+$11.88 M+39.04%

June 30, 2024

Summary

Performance

1-Year Change

+39.04%

3-Year Change

+38.28%

5-Year Change

-32.77%

15-Year Change

-40.96%

IBIO Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

48.74%
IBIO annual cash flow from operations is higher than 48.74% of companies in Healthcare sector

High & Low

All-time High

-$849.40 K

3-Year Low

-$37.48 M

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
IBIO previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
IBIO next annual earnings announcement has not yet been scheduled

OtherIBIOcash flowmetrics:

Annual CFI

$906.00 K
IBIO annual cash flow from investing activities is $906.00 thousand

Annual CFF

$24.49 M
IBIO annual cash flow from financing activities is $24.49 million

Annual FCF

-$18.76 M
IBIO annual free cash flow is -$18.76 million

Annual CAPEX

$210.00 K
IBIO annual capital expenditures is $210.00 thousand

Quarterly CFO

-$3.71 M
+$1.14 M+23.47%

September 30, 2024

Summary

Performance

3-Month Change

+23.47%

1-Year Change

+23.47%

3-Year Change

+4.05%

5-Year Change

+4.05%

IBIO Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

49.74%
IBIO quarterly cash flow from operations is higher than 49.74% of companies in Healthcare sector

High & Low

All-time High

-$188.50 K

3-Year Low

-$13.96 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
IBIO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
IBIO next earnings announcement has not yet been scheduled

OtherIBIOcash flowmetrics:

Quarterly CFI

$713.00 K
IBIO quarterly cash flow from investing activities is $713.00 thousand

Quarterly CFF

-$162.00 K
IBIO quarterly cash flow from financing activities is -$162.00 thousand

Quarterly FCF

-$3.71 M
IBIO quarterly free cash flow is -$3.71 million

Quarterly CAPEX

-
IBIO quarterly capital expenditures value is unknown

TTM CFO

-$16.93 M
+$1.63 M+8.76%

September 30, 2024

Summary

Performance

3-Month Change

+8.76%

1-Year Change

+8.76%

3-Year Change

+54.21%

5-Year Change

+54.21%

IBIO TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

49.22%
IBIO TTM cash flow from operations is higher than 49.22% of companies in Healthcare sector

High & Low

All-time High

-$439.20 K

3-Year Low

-$42.09 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
IBIO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
IBIO next earnings announcement has not yet been scheduled

OtherIBIOcash flowmetrics:

TTM CFI

$1.57 M
IBIO TTM cash flow from investing activities is $1.57 million

TTM CFF

$21.86 M
IBIO TTM cash flow from financing activities is $21.86 million

TTM FCF

-$16.93 M
IBIO TTM free cash flow is -$16.93 million

TTM CAPEX

-
IBIO TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

IBIO Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+39.0%+23.5%+8.8%
3 y3 years+38.3%+4.0%+54.2%
5 y5 years-32.8%+4.0%+54.2%

IBIO Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+50.5%-1.7%+73.4%at high+59.8%
5 y5-year-39.0%+50.5%-9.1%+73.4%-26.9%+59.8%
alltimeall time-2084.4%+50.5%-1870.8%+73.4%-3754.5%+59.8%

IBio Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$3.71 M(-23.5%)
-$16.93 M(-8.8%)
Jun 2024
-$18.55 M(-39.0%)
-$4.85 M(+32.8%)
-$18.55 M(-0.6%)
Mar 2024
-
-$3.65 M(-22.4%)
-$18.67 M(-1.2%)
Dec 2023
-
-$4.71 M(-11.9%)
-$18.89 M(-13.4%)
Sep 2023
-
-$5.34 M(+7.4%)
-$21.82 M(-28.3%)
Jun 2023
-$30.44 M(-18.8%)
-$4.97 M(+28.4%)
-$30.44 M(-17.7%)
Mar 2023
-
-$3.87 M(-49.3%)
-$36.97 M(-5.3%)
Dec 2022
-
-$7.63 M(-45.3%)
-$39.04 M(-7.2%)
Sep 2022
-
-$13.96 M(+21.4%)
-$42.09 M(+12.3%)
Jun 2022
-$37.48 M(+24.7%)
-$11.50 M(+93.5%)
-$37.48 M(+12.9%)
Mar 2022
-
-$5.94 M(-44.4%)
-$33.20 M(-4.1%)
Dec 2021
-
-$10.69 M(+14.3%)
-$34.61 M(+7.0%)
Sep 2021
-
-$9.35 M(+29.4%)
-$32.34 M(+7.6%)
Jun 2021
-$30.06 M(+125.3%)
-$7.23 M(-1.7%)
-$30.06 M(+12.6%)
Mar 2021
-
-$7.35 M(-12.7%)
-$26.70 M(+15.4%)
Dec 2020
-
-$8.42 M(+19.1%)
-$23.14 M(+27.7%)
Sep 2020
-
-$7.07 M(+82.8%)
-$18.13 M(+35.8%)
Jun 2020
-$13.35 M(-4.5%)
-$3.87 M(+2.1%)
-$13.35 M(-3.8%)
Mar 2020
-
-$3.79 M(+11.2%)
-$13.87 M(-2.5%)
Dec 2019
-
-$3.40 M(+48.9%)
-$14.22 M(-8.2%)
Sep 2019
-
-$2.29 M(-47.9%)
-$15.48 M(+10.8%)
Jun 2019
-$13.97 M(+3.7%)
-$4.39 M(+6.2%)
-$13.97 M(+7.8%)
Mar 2019
-
-$4.13 M(-11.5%)
-$12.96 M(+5.2%)
Dec 2018
-
-$4.67 M(+500.3%)
-$12.32 M(+9.6%)
Sep 2018
-
-$778.00 K(-76.9%)
-$11.24 M(-16.6%)
Jun 2018
-$13.48 M(+2.4%)
-$3.38 M(-3.6%)
-$13.48 M(-2.8%)
Mar 2018
-
-$3.50 M(-2.5%)
-$13.87 M(-0.4%)
Dec 2017
-
-$3.59 M(+18.9%)
-$13.93 M(+0.2%)
Sep 2017
-
-$3.02 M(-19.9%)
-$13.91 M(+5.7%)
Jun 2017
-$13.16 M(+63.1%)
-$3.77 M(+5.7%)
-$13.16 M(+7.7%)
Mar 2017
-
-$3.56 M(-0.1%)
-$12.22 M(+10.1%)
Dec 2016
-
-$3.56 M(+56.8%)
-$11.10 M(+20.6%)
Sep 2016
-
-$2.27 M(-19.5%)
-$9.20 M(+13.9%)
Jun 2016
-$8.07 M
-$2.82 M(+15.8%)
-$8.07 M(+25.0%)
Mar 2016
-
-$2.44 M(+46.1%)
-$6.46 M(+20.8%)
DateAnnualQuarterlyTTM
Dec 2015
-
-$1.67 M(+45.3%)
-$5.35 M(+0.8%)
Sep 2015
-
-$1.15 M(-5.0%)
-$5.30 M(+12.2%)
Jun 2015
-$4.72 M(+14.8%)
-$1.21 M(-8.9%)
-$4.72 M(+12.4%)
Mar 2015
-
-$1.32 M(-18.4%)
-$4.20 M(+2.4%)
Dec 2014
-
-$1.62 M(+184.7%)
-$4.10 M(+8.7%)
Sep 2014
-
-$570.00 K(-16.7%)
-$3.77 M(-8.3%)
Jun 2014
-$4.12 M(-15.1%)
-$684.00 K(-44.3%)
-$4.12 M(-5.2%)
Mar 2014
-
-$1.23 M(-5.2%)
-$4.34 M(-0.4%)
Dec 2013
-
-$1.29 M(+42.0%)
-$4.36 M(-2.5%)
Sep 2013
-
-$911.00 K(+0.2%)
-$4.47 M(-7.8%)
Jun 2013
-$4.85 M(-19.3%)
-$909.00 K(-27.0%)
-$4.85 M(-2.6%)
Mar 2013
-
-$1.25 M(-11.3%)
-$4.98 M(-25.6%)
Dec 2012
-
-$1.40 M(+8.8%)
-$6.69 M(+10.2%)
Sep 2012
-
-$1.29 M(+24.0%)
-$6.07 M(+1.0%)
Jun 2012
-$6.01 M(+12.6%)
-$1.04 M(-64.8%)
-$6.01 M(-1.0%)
Mar 2012
-
-$2.96 M(+277.1%)
-$6.07 M(+18.5%)
Dec 2011
-
-$784.10 K(-36.2%)
-$5.12 M(-15.2%)
Sep 2011
-
-$1.23 M(+11.8%)
-$6.04 M(+13.2%)
Jun 2011
-$5.34 M(+127.3%)
-$1.10 M(-45.3%)
-$5.34 M(+12.2%)
Mar 2011
-
-$2.01 M(+17.8%)
-$4.76 M(+16.3%)
Dec 2010
-
-$1.71 M(+224.0%)
-$4.09 M(+56.5%)
Sep 2010
-
-$526.20 K(+1.5%)
-$2.62 M(+11.4%)
Jun 2010
-$2.35 M(+16.0%)
-$518.40 K(-61.4%)
-$2.35 M(+15.9%)
Mar 2010
-
-$1.34 M(+489.1%)
-$2.03 M(+118.0%)
Dec 2009
-
-$227.90 K(-12.1%)
-$929.80 K(-38.3%)
Sep 2009
-
-$259.40 K(+31.9%)
-$1.51 M(-25.6%)
Jun 2009
-$2.02 M(+76.1%)
-$196.70 K(-20.0%)
-$2.02 M(-0.0%)
Mar 2009
-
-$245.80 K(-69.4%)
-$2.03 M(-3.7%)
Dec 2008
-
-$804.30 K(+3.4%)
-$2.10 M(+41.4%)
Sep 2008
-
-$778.10 K(+293.8%)
-$1.49 M(+29.5%)
Jun 2008
-$1.15 M(+35.3%)
-$197.60 K(-39.0%)
-$1.15 M(+20.8%)
Mar 2008
-
-$324.20 K(+72.0%)
-$951.90 K(+51.6%)
Dec 2007
-
-$188.50 K(-57.1%)
-$627.70 K(+42.9%)
Sep 2007
-
-$439.20 K
-$439.20 K
Jun 2007
-$849.40 K
-
-

FAQ

  • What is iBio annual cash flow from operations?
  • What is the all time high annual CFO for iBio?
  • What is iBio annual CFO year-on-year change?
  • What is iBio quarterly cash flow from operations?
  • What is the all time high quarterly CFO for iBio?
  • What is iBio quarterly CFO year-on-year change?
  • What is iBio TTM cash flow from operations?
  • What is the all time high TTM CFO for iBio?
  • What is iBio TTM CFO year-on-year change?

What is iBio annual cash flow from operations?

The current annual CFO of IBIO is -$18.55 M

What is the all time high annual CFO for iBio?

iBio all-time high annual cash flow from operations is -$849.40 K

What is iBio annual CFO year-on-year change?

Over the past year, IBIO annual cash flow from operations has changed by +$11.88 M (+39.04%)

What is iBio quarterly cash flow from operations?

The current quarterly CFO of IBIO is -$3.71 M

What is the all time high quarterly CFO for iBio?

iBio all-time high quarterly cash flow from operations is -$188.50 K

What is iBio quarterly CFO year-on-year change?

Over the past year, IBIO quarterly cash flow from operations has changed by +$1.14 M (+23.47%)

What is iBio TTM cash flow from operations?

The current TTM CFO of IBIO is -$16.93 M

What is the all time high TTM CFO for iBio?

iBio all-time high TTM cash flow from operations is -$439.20 K

What is iBio TTM CFO year-on-year change?

Over the past year, IBIO TTM cash flow from operations has changed by +$1.63 M (+8.76%)